NNCSF 股息： Nanosonics Limited 收益洞察

Q: Nanosonics Limited 的关键财务报表是什么？

根据最新的财务报表（Form-10K），Nanosonics Limited 的总资产为 $272，净利润为 $20

Q: NNCSF 的关键财务比率是什么？

Nanosonics Limited 的流动比率是 4.38，净利 margin 为 10.1，每股销售为 $0.64。

Q: Nanosonics Limited 的收入按细分市场或地理位置如何划分？

Nanosonics Limited 最大收入来源是 Other，在最近的收益报告中收入为 -17,366,765。就地区而言， Canada 是 Nanosonics Limited 的主要市场，收入为 625,000,000。

Q: Nanosonics Limited 是否盈利？

是的，根据最新的财务报表，Nanosonics Limited 的净利润为 $20

Q: Nanosonics Limited 有负债吗？

是的，Nanosonics Limited 的负债为 62

Q: Nanosonics Limited 的流通股有多少？

Nanosonics Limited 的总流通股为 303.63

主页

股票

NNCSF

NNCSF 财务

Nanosonics Limited

$2.6

截至今日：Jan 22, 13:59:47 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$2.6

开盘价

$2.55

当日区间

$2.55 - $2.6

52周范围

$2.1 - $3.3

交易量

400

平均成交量

155

每股收益（TTM）

0.04

股息收益率

市值

$788.6M

什么是 Nanosonics Ltd.？

Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. The company is headquartered in Sydney, New South Wales and currently employs 470 full-time employees. The company went IPO on 2007-05-17. The firm's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. The company is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. Its trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.

功能特性

交易策略

资源

市场

收入

资产负债表

现金流量

年度

季度性

NNCSF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
营收	198	198	170	165	120	103
营收同比增长 (YoY)	16%	16%	3%	38%	17%	3%
营收成本	43	43	37	35	28	22
毛利润	155	155	132	130	91	80
销售、一般及管理费用	104	99	88	80	63	50
研发	34	32	30	27	21	16
营业费用	137	137	123	112	90	70
其他非经营性收入 (费用)	-1	-1	0	0	0	--
税前利润	22	22	12	21	1	10
所得税费用	1	1	0	1	-2	2
净利润	20	20	12	19	3	8
净利润增长	67%	67%	-37%	533%	-63%	-20%
稀释后流通股数	309.39	309.14	308.88	306.29	305.6	305.15
股份同比变动 (YoY)	-1%	0%	1%	0%	0%	0%
每股收益 (摊薄)	0.06	0.06	0.04	0.06	0.01	0.02
每股收益增长率	59%	59%	-35%	432%	-56.99%	-16%
自由现金流	35	35	20	19	0	5
每股自由现金流	--	--	--	--	--	--
毛利率	78.28%	78.28%	77.64%	78.78%	75.83%	77.66%
营业利润率	8.58%	8.58%	4.7%	10.3%	0.83%	8.73%
净利率	10.1%	10.1%	7.05%	11.51%	2.5%	7.76%
自由现金流利润率	17.67%	17.67%	11.76%	11.51%	0%	4.85%
EBITDA	--	24	14	23	6	13
EBITDA 利润率	--	12.12%	8.23%	13.93%	5%	12.62%
EBITDA 中的折旧与摊销	--	7	6	6	5	4
EBIT	17	17	8	17	1	9
EBIT 利润率	8.58%	8.58%	4.7%	10.3%	0.83%	8.73%
有效税率	4.54%	4.54%	0%	4.76%	-200%	20%

Follow-Up Questions

Nanosonics Limited 的关键财务报表是什么？



NNCSF 的关键财务比率是什么？



Nanosonics Limited 的收入按细分市场或地理位置如何划分？



Nanosonics Limited 是否盈利？



Nanosonics Limited 有负债吗？



Nanosonics Limited 的流通股有多少？



Nanosonics Limited（NNCSF）价格

NNCSF 股价走势图